The DOI matches its Crossref record.
Shwachman–Diamond Syndrome
Open accessAbstract
In 1964, five patients showing evidence of exocrine pancreatic insufficiency and leucopenia were described (Shwachman et al, 1964). The syndrome, later termed Shwachman–Diamond syndrome (SDS), was described earlier by Nezelof & Watchi (1961) and a few months later by Bodian et al (1964). Burke et al (1967) and Pringle et al (1968) observed associated skeletal changes of the metaphyseal dysostosis type, which became the third fundamental feature of the syndrome. Aggett et al (1980) described 21 cases of SDS in detail and defined the scope of the syndrome as currently understood. SDS has also been called 'Shwachman syndrome', 'Shwachman–Bodian syndrome' and 'congenital lipomatosis of the pancreas. Although SDS is a rare disorder, it is the most common cause of pancreatic insufficiency in children next to cystic fibrosis and probably the third most common inherited bone marrow failure syndrome after Fanconi's anaemia and Diamond–Blackfan anaemia. It mainly involves the pancreas, bone marrow and skeleton, but the liver, kidneys, teeth and immune system may also be affected (Aggett et al, 1980; Mack et al, 1996; Ginzberg et al, 1999; Dror et al, 2001). Haematologically, SDS is characterized by varying degrees of cytopenia and a high risk of development of myelodysplastic syndrome (MDS) and leukaemia, making it an important model for genetic determinants of bone marrow failure and leukaemia. Studies of family pedigrees support an autosomal recessive mode of inheritance (Ginzberg et al, 1999). The SDS locus has recently been mapped to the centromeric region of chromosome 7 (7p10–7q11) (Goobie et al, 2001). The gene responsible for this complex, pleiotropic phenotype should be identified soon, and the molecular basis for the multisystem features, bone marrow failure and leukaemic transformation may be clarified. SDS manifests itself in many and various combinations, shown in Table I. Results of two retrospective studies (Mack et al, 1996; Smith et al, 1996) and a cross-sectional multicentre study (Ginzberg et al, 1999) have recently been published, adding significantly to our understanding of the clinical phenotype and probably representing the spectrum of clinical findings fairly accurately. Neutropenia. Neutropenia is the most common haematological abnormality, occurring in 88–100% of patients and has been identified as early as the neonatal period. In most cases the neutropenia is intermittent and fluctuates within the same patient from severely low to normal levels. Cyclic patterns without detailed information on the timing of cycling have also been reported (Dokal et al, 1997). However, cyclical haematopoiesis was not observed in the series described by Aggett et al (1980), Mack et al (1996) or Smith et al (1996) or among 16 SDS patients followed at our institution (unpublished observations). Impaired neutrophil chemotaxis. SDS neutrophils may have defects in mobility, migration and chemotaxis in most (Cipolli et al, 1999; Maserati et al, 2000) or all patients (Smith et al, 1996; Dror et al, 2001). Alterations in neutrophil cytoskeletal/microtubular integrity and function may play a prominent role in causing the defective chemotaxis. Rothbaum et al, (1982) demonstrated abnormal distribution of concanavalin-A receptors on polymorphonuclear leucocytes. Lithium appears to restore chemotaxis when used in vitro (Azzaràet al, 1988) and in vivo (Azzaràet al, 1991). Anaemia. Anaemia with low reticulocytes was recorded in up to 80% of patients in the reports reviewed. It was usually mild and normochromic-normocytic. However, macrocytosis has been described (Woods et al, 1981a) and three of 16 SDS patients we studied had macrocytic red blood cells (unpublished observations). Fetal haemoglobin was elevated in 80% of patients (Dror & Freedman, 1999). The elevation of heterogeneously distributed fetal haemoglobin reflects 'stress' haematopoiesis and/or ineffective erythropoiesis related to apoptosis and is also seen in all types of MDS. Thrombocytopenia. Thrombocytopenia, defined by platelets < 150 × 109/l, was seen in 24% to 88% of patients. Easy bruising may occur. Fatal bleeding while the patients had moderate to severe thrombocytopenia has also been reported (Nezelof & Watchi, 1961; Caselitz et al, 1979; Woods et al, 1981a; Gretillat et al, 1985; Okcu et al, 1998; Maserati et al, 2000). Pancytopenia. Trilineage cytopenia occurs in 10–65% of patients. Both anaemia and thrombocytopenia are usually mild to moderate in these cases but neutropenia tends to be more severe. Pancytopenia in SDS with hypoplasia of three bone marrow lineages might carry a poor prognosis, with a higher chance of developing symptomatic severe aplasia, advanced MDS or acute myeloid leukaemia (AML) (Mack et al, 1996). Severe aplasia requiring transfusion has been reported (Woods et al, 1981a; Tsai et al, 1990; Barrios et al, 1991). In the series reported by Aggett et al (1980), four of the 21 patients were transfusion dependent. Bone marrow findings
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Alter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356
The impact of rare variation on gene expression across tissues
GTEx Consortium, Li, X., Kim, Y., Tsang, E. K., Davis, J. R., Damani, F. N., Chiang, C., Hess, G. T., Zappala, Z., Strober, B. J., et al. (2017) · Nature · doi:10.1038/nature24267 · Cited by 257
Tourlakis, M. E., Zhang, S., Ball, H. L., Gandhi, R., Liu, H., Zhong, J., Yuan, J. S., Guidos, C. J., Durie, P. R., & Rommens, J. M. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005288 · Cited by 47
Metadata
- Authors
- Dror, Y., & Freedman, M. H.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2002-08-15
- Volume
- 118
- Issue
- 3
- Pages
- 701-713
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1564251925
- Cited by
- 211
- References
- 0
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Shwachman–Diamond Syndrome. https://app.cochat.ai/papers/10.1046/j.1365-2141.2002.03585.x
- The paper
- Dror, Y., & Freedman, M. H. (2002). Shwachman–Diamond Syndrome. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.2002.03585.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.